ACA Parity Requirements for Substance Use Disorder Treatment

Federal law requires that health insurers treat substance use disorder (SUD) benefits the same way they treat medical and surgical benefits — a mandate with teeth that has reshaped how millions of Americans access addiction treatment. The rules stem from two overlapping laws: the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA) and the Affordable Care Act of 2010 (ACA), which together closed a long-standing loophole that let insurers apply stricter limits to behavioral health than to, say, a knee replacement. Getting familiar with these rules isn't just bureaucratic housekeeping — it can mean the difference between a covered stay in residential treatment and a five-figure bill someone didn't see coming.

Definition and scope

The MHPAEA established the parity principle: if a health plan covers mental health or substance use disorder treatment, that coverage cannot be more restrictive than the "predominant" limitations applied to medical and surgical benefits. The ACA expanded this requirement dramatically by making SUD treatment one of ten essential health benefits (EHBs) that qualified health plans sold on the ACA marketplaces must cover. This means parity isn't just about fairness between two equal benefits — it's about guaranteeing the benefit exists in the first place.

The scope is broad but not universal. The MHPAEA applies to employer-sponsored group health plans with more than 50 employees, individual and small group plans sold on the ACA marketplaces, and Medicaid managed care organizations. Plans that cover fewer than 50 employees and grandfathered individual market plans are exempt from the EHB mandate, though state law may fill the gap. The Consolidated Appropriations Act of 2021 added new disclosure requirements, giving enrollees the right to request comparative analyses showing how a plan applies its treatment limitations (CMS MHPAEA guidance).

How it works

Parity operates across three types of limitations:

1. Quantitative treatment limits (QTLs): Caps measured in numbers — days of inpatient coverage, outpatient visit maximums, annual dollar limits. A plan cannot cap inpatient SUD rehab at 30 days if it covers 60 days for comparable medical conditions.
2. Non-quantitative treatment limits (NQTLs): The subtler category, and historically the bigger enforcement problem. NQTLs include prior authorization requirements, step therapy protocols (requiring a patient to try and fail a cheaper treatment first), residential treatment criteria, and network adequacy standards. Under MHPAEA, the processes and standards used to set these limits must be comparable to those used for medical benefits.
3. Financial requirements: Deductibles, copayments, coinsurance, and out-of-pocket maximums must not be more restrictive for SUD benefits than for medical or surgical benefits in the same classification.

The Department of Labor, HHS, and the Treasury share enforcement authority, a jurisdictional arrangement that — to put it charitably — has occasionally produced more guidance documents than enforcement actions. The Biden administration's 2024 final rule on MHPAEA strengthened the NQTL standard by requiring plans to demonstrate, using "meaningful metrics," that NQTLs actually perform comparably in practice, not just on paper (DOL MHPAEA 2024 Final Rule).

Common scenarios

Prior authorization for residential treatment. A plan requires pre-approval for SUD residential stays but not for medical inpatient admissions of comparable acuity. Under parity rules, this is a textbook NQTL violation — the standard cannot be applied more stringently to addiction treatment than to medical treatment. Anyone encountering this situation can find help navigating the appeal process.

Step therapy for medication-assisted treatment (MAT). A plan requires a patient to demonstrate failure on one opioid use disorder medication before approving another — a protocol not applied to, say, blood pressure medications. This qualifies as an NQTL and must be evaluated under the same standards used for medical drugs.

Out-of-network reimbursement gaps. SUD treatment providers are chronically underrepresented in insurer networks. The 2024 final rule specifically targets network adequacy as an NQTL, requiring plans to analyze whether SUD network composition is comparable to the medical network. Where it isn't, the plan may be in violation even without any explicit policy targeting behavioral health.

Lifetime and annual dollar limits. The ACA prohibits lifetime and annual dollar limits on EHBs, which include SUD treatment. A plan cannot cap SUD benefits at $10,000 per year while covering unlimited medical costs.

Decision boundaries

Parity rules are not a guarantee of unlimited coverage — they guarantee equal coverage. If a plan covers 30 inpatient days for all conditions, 30 days for SUD is parity-compliant even if 30 days is clinically insufficient. The law sets a floor of equality, not a floor of adequacy.

The classification system matters. MHPAEA divides benefits into six classifications: inpatient in-network, inpatient out-of-network, outpatient in-network, outpatient out-of-network, emergency care, and prescription drugs. Parity is evaluated within each classification, not across them. A plan cannot satisfy parity in the inpatient category by pointing to generous outpatient SUD coverage.

Enforcement has teeth but requires active use. The 2024 final rule created a phased compliance deadline — plans must submit NQTL comparative analyses and remedy any identified deficiencies within specified timeframes. Enrollees who suspect a violation can file complaints with the DOL's Employee Benefits Security Administration for employer-sponsored plans, or with their state insurance commissioner for marketplace plans. The frequently asked questions resource covers how denial and appeals timelines typically unfold.

The distinction between a grandfathered plan and a non-grandfathered plan is one of the more consequential details in this landscape — grandfathered individual market plans predate the ACA's EHB requirements and are not bound by them, though they still fall under MHPAEA if they offer SUD benefits at all. For a broader view of how rehab coverage and access intersect, the underlying mechanics of treatment financing deserve equal attention alongside the legal framework that governs it.